GR1001151B - Νεα xρηση θειορεδοξινης - Google Patents

Νεα xρηση θειορεδοξινης

Info

Publication number
GR1001151B
GR1001151B GR900100679A GR900100679A GR1001151B GR 1001151 B GR1001151 B GR 1001151B GR 900100679 A GR900100679 A GR 900100679A GR 900100679 A GR900100679 A GR 900100679A GR 1001151 B GR1001151 B GR 1001151B
Authority
GR
Greece
Prior art keywords
pharmaceutical use
novel pharmaceutical
novel
thioredoxin
malignancies
Prior art date
Application number
GR900100679A
Other languages
English (en)
Other versions
GR900100679A (en
Inventor
Anders Rosen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of GR900100679A publication Critical patent/GR900100679A/el
Publication of GR1001151B publication Critical patent/GR1001151B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y108/00—Oxidoreductases acting on sulfur groups as donors (1.8)
    • C12Y108/01—Oxidoreductases acting on sulfur groups as donors (1.8) with NAD+ or NADP+ as acceptor (1.8.1)
    • C12Y108/01008—Protein-disulfide reductase (1.8.1.8), i.e. thioredoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η χρήση θειορεδοξίνης στη θεραπεία Β λεμφοκυτταρικής λευχαιμίας και ορισμένων άλλων κακοηθών νόσων. ω
GR900100679A 1989-09-12 1990-09-10 Νεα xρηση θειορεδοξινης GR1001151B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8903003A SE8903003D0 (sv) 1989-09-12 1989-09-12 Novel medical use

Publications (2)

Publication Number Publication Date
GR900100679A GR900100679A (en) 1992-01-20
GR1001151B true GR1001151B (el) 1993-05-24

Family

ID=20376862

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100679A GR1001151B (el) 1989-09-12 1990-09-10 Νεα xρηση θειορεδοξινης

Country Status (12)

Country Link
EP (1) EP0489113A1 (el)
JP (1) JPH05500216A (el)
AU (1) AU641942B2 (el)
CA (1) CA2065454A1 (el)
DD (1) DD298056A5 (el)
FI (1) FI921058A0 (el)
GR (1) GR1001151B (el)
HU (1) HUT62932A (el)
IE (1) IE903233A1 (el)
PT (1) PT95284A (el)
SE (1) SE8903003D0 (el)
WO (1) WO1991004320A1 (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744877B2 (en) 1992-11-13 2010-06-29 Biogen Idec Inc. Expression and use of anti-CD20 Antibodies
DK0669836T3 (da) 1992-11-13 1996-10-14 Idec Pharma Corp Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænset differentieringsantigen til behandling af B-cellelymfom
WO1998000160A1 (en) * 1996-06-28 1998-01-08 Nat Jewish Ct Immun & Respirat USE OF THIOREDOXIN-LIKE MOLECULES FOR INDUCTION OF MnSOD TO TREAT OXIDATIVE DAMAGE
EP0946192A1 (en) * 1996-12-06 1999-10-06 Garth Powis Uses of thioredoxin
US6689775B2 (en) 1999-06-03 2004-02-10 Arizona Board Of Regents, Acting On Behalf Of The University Of Arizona Uses of thioredoxin
US5919657A (en) * 1997-04-09 1999-07-06 Incyte Pharmaceuticals, Inc. Nucleic acids encoding human thioredoxin protein; related reagents
US7585645B2 (en) 1997-05-27 2009-09-08 Sembiosys Genetics Inc. Thioredoxin and thioredoxin reductase containing oil body based products
KR20010040448A (ko) 1998-01-30 2001-05-15 진센스 테크놀로지즈 인코포레이티드 티오레독신 또는 티오레독신 환원효소의 유전자와상보적인 올리고뉴클레오 타이드 서열 및 이들을 사용하는세포성장 조절 방법
NZ528199A (en) 1998-08-11 2005-06-24 Idec Pharma Corp Combination therapies for B-cell lyphomas comprising administration of anti-CD20 antibody
PT1616572E (pt) 1998-11-09 2010-11-11 Biogen Idec Inc Anticorpo quimérico anti-cd20, rituxan, para utilização no tratamento de leucemia linfocítica crónica
US8557244B1 (en) 1999-08-11 2013-10-15 Biogen Idec Inc. Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody
WO2002016600A2 (en) * 2000-08-25 2002-02-28 Curagen Corporation Novel proteins and nucleic acids encoding same
US7195766B2 (en) * 2002-09-10 2007-03-27 National Jewish Medical And Research Center Product and process for liquefaction of mucus or sputum
KR20160007496A (ko) 2013-03-15 2016-01-20 오프로 테라퓨틱스 인코퍼레이션 점액 점도 정상화를 위한 생성물 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2633295B2 (ja) * 1987-06-12 1997-07-23 味の素株式会社 ヒトａｄｆをコードする遺伝子

Also Published As

Publication number Publication date
FI921058A0 (fi) 1992-03-11
AU6433690A (en) 1991-04-18
HU9200821D0 (en) 1992-05-28
GR900100679A (en) 1992-01-20
CA2065454A1 (en) 1991-03-13
EP0489113A1 (en) 1992-06-10
DD298056A5 (de) 1992-02-06
HUT62932A (en) 1993-06-28
PT95284A (pt) 1991-08-14
IE903233A1 (en) 1991-03-27
JPH05500216A (ja) 1993-01-21
WO1991004320A1 (en) 1991-04-04
SE8903003D0 (sv) 1989-09-12
AU641942B2 (en) 1993-10-07

Similar Documents

Publication Publication Date Title
DE3786205D1 (de) Titanocene und deren verwendung.
IT8567521A1 (it) Apparecchiatura e procedimento per rilevare le variazioni, nel tempo, di caratteristiche di una zona o dell'insieme di una persona, ed applicazioni del procedimento.
NO872412L (no) Fremgangsmaate og anordning til avgivelse av et middel i et biologisk miljoe.
DE68924477D1 (de) Gleitkommaeinheit mit gleichzeitiger Multiplikation und Addition.
DE3789518D1 (de) Verbundfolie und antistatische Verbundfolie.
NO894587D0 (no) Glassblanding for anvendelse i glasur og emalje.
GR1001151B (el) Νεα xρηση θειορεδοξινης
IT8819498A0 (it) Prodotto disinfestante e suo impiego.
NO871581D0 (no) Synergistisk kombinasjon av amantadin og selegilin.
DE3784199D1 (de) Titanocene und deren verwendung.
TR28384A (tr) Flüoroalifatik -ve karboksil- iceren terminal gruplarina sahip polisilokzanlar, bunlarin hazirlanmasi, ve lifli malzemelerin muamelesinde kullanimlari.
DE3583023D1 (de) Ionomerharzfilme und verbundstoffe daraus.
DE3884291D1 (de) Phasenverzögernde Polymerfilme und polarisierende Bauteile.
DE3780209D1 (de) Dreh- und kipptisch.
DE3887977D1 (de) Buten-1-Polymer-Film und damit laminierter Film.
DE3880480D1 (de) Hemolyse-inhibitor und plastifizierungsmittel.
NO871053L (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
DE3762612D1 (de) Vermiculitformmassen und daraus hergestellte artikel.
NO891122D0 (no) Platinakoordinasjonsforbindelser og anvendelse av forbindelsene i kjemoterapi.
DE3870316D1 (de) Photoinitiator und photopolymerisierbare zusammensetzung damit.
DE3785107D1 (de) Prepreg und dessen komposit.
DE3673672D1 (de) Gefrierresistenter teig und darin verwendbarer mikroorganismus.
DE3763939D1 (de) Nadimido-substituierte cyclophosphazene und hitzegehaertete gegenstaende.
IT1211251B (it) Accessorio utilizzabile nel campo pubblicitario e promozionale
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases